TGFB1 and neoplasm: However, like conventional radiotherapy, HDRT can suppress tumor-reactive immunity by increasing the infiltration of Tregs and MDSCs, inducing an M2-like phenotype, and releasing TGF-β and IL-10 (143, 174).